- 747.8 - 679.6 10.0% Selling expenses - 20.1 - 15.9 26.3% Administrative expenses - 44.0 - 45.0 -2.2% Finance costs - 7.9 - 11.4 -30.3% Profit for the period 42.6 131.7 -67.7% Net Profit 4.9% 14.5% EBITDA

income 4.1 6.1 -32.5% Cost of sales - 159.6 - 150.9 -5.8% Selling expenses - 4.5 - 5.6 19.8% Administrative expenses - 7.2 - 6.6 -9.4% Finance costs - 3.0 - 0.7 -298.0% Profit for the period 2.4 11.9 -79.9

the 2nd Quarter of 2017 Ending June 30, 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4/2017

for the 3rd Quarter of 2017 Ending 30 September 2017 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 5

and Analysis Quarterly Ending June 30, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 3/2019

2018 Change Change (%) Selling expenses 134 170 (36) (21) Administrative expenses 450 395 55 14 Finance cost 103 84 19 23 Income tax expenses 36 122 (86) (70) 1) Selling expenses in the second quarter of

and Analysis Quarterly Ending September 30, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4/2018

) - Loss on exchange rate - (32.95) - - - (32.95) Finance costs (34.18) (19.56) - - (34.18) (19.56) SHARE OF LOSS OF INVESTMENT IN JOINT VENTURES ON EQUITY METHOD (0.35) (0.65) - - (0.35) (0.65) LOSS BEFORE

Gain (loss) on exchange rate 9,368 (5,944) (15,312) 257.60 Profit (loss) before Finance cost and Income Tax (23,472) (18,922) (4,550) 24.05 Finance Costs (4,135) (1,755) 2,380 (135.61) Profit (loss

% Administrative expenses - 2.6 - 9.6 73.1% Finance costs - 4.5 - 3.1 -46.3% Profit for the period 28.4 17.2 64.7% Net Profit 10.3% 9.1% EBITDA (MB) 45.9 27.8 65.4% EBITDA (%) 16.6% 14.6% Earnings per share (Baht